NCT05635734 2026-02-05Azeliragon and Chemoradiotherapy in Newly Diagnosed GlioblastomaCantex PharmaceuticalsPhase 1/2 Active not recruiting18 enrolled
NCT05986851 2024-09-05Azeliragon in MGMT Unmethylated GlioblastomaCantex PharmaceuticalsPhase 2 Active not recruiting30 enrolled
NCT05766748 2024-06-14Study of Effect of Azeliragon in Patients Refractory to Prior Treatment of Metastatic Pancreatic CancerCantex PharmaceuticalsPhase 1/2 Recruiting30 enrolled